1-8 of 8
Sort by
News

The Year in FDA Approvals 2017 (Focus On Myeloid)

Published: 2021
View News titled, The Year in FDA Approvals 2017 (Focus On Myeloid)
News

Non-Engineered T Cells to Prevent or Treat Relapse in Post-Transplant AML/MDS

Published: 2021
View News titled, Non-Engineered T Cells to Prevent or Treat Relapse in Post-Transplant AML/MDS
News

Prognostic Significance of Post-Transplant MRD Varies Based on Conditioning Regimen in ALL

Published: 2021
View News titled, Prognostic Significance of Post-Transplant MRD Varies Based on Conditioning Regimen in ALL
News

Five Decades of Experience With MPNs: Characterizing Survival and Outcomes

Published: 2021
View News titled, Five Decades of Experience With MPNs: Characterizing Survival and Outcomes
News

CMML: A Unique Overlap Syndrome Receiving Increased Attention

Published: 2021
View News titled, CMML: A Unique Overlap Syndrome Receiving Increased Attention
News

CHIP-Associated Mutations Linked With Comorbidities in MDS

Published: 2021
View News titled, CHIP-Associated Mutations Linked With Comorbidities in MDS
News

RADIUS: Midostaurin Reduces Post-Transplant Relapse Risk in FLT3-Mutated AML

Published: 2021
View News titled, RADIUS: Midostaurin Reduces Post-Transplant Relapse Risk in FLT3-Mutated AML
News

New Treatment Options Lead to New Questions in Acute Myeloid Leukemia

Published: 2021
View News titled, New Treatment Options Lead to New Questions in Acute Myeloid Leukemia